Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Treatment source : Ir.auriniapharma.com save search
Aurinia Response in Support of 2023 Updated EULAR Recommendations for Management of Lupus and New Treatment Paradigm for Lupus Nephritis
Published: 2023-10-26 (Crawled : 19:00) - ir.auriniapharma.com
AUPH | $5.085 0.69% 0.59% 920K
|
Health Technology
|
| O: 0.0%
H: 0.82%
C: -1.91%
management lupus treatment response
Aurinia Pharmaceuticals Announces New and Refined Method of Use Patent for LUPKYNIS® in the Treatment of Lupus Nephritis Issued by United States Patent and Trademark Office
Published: 2023-04-11 (Crawled : 14:20) - ir.auriniapharma.com
AUPH | $5.085 0.69% 0.59% 920K
|
Health Technology
|
| O: 1.01%
H: 11.13%
C: 9.73%
lupkynis patent lupus treatment pharmaceuticals
Aurinia Pharmaceuticals Announces Allowance of a New and Refined Method of Use Patent for LUPKYNIS® in the Treatment of Lupus Nephritis From the United States Patent and Trademark Office
Published: 2023-01-24 (Crawled : 21:00) - ir.auriniapharma.com
AUPH | $5.085 0.69% 0.59% 920K
|
Health Technology
|
| O: 8.16%
H: 2.31%
C: 1.91%
lupkynis treatment pharmaceuticals patent lupus
Aurinia Announces the Great Britain Marketing Authorization of LUPKYNIS® (voclosporin) for the Treatment of Lupus Nephritis
Published: 2022-11-30 (Crawled : 21:00) - ir.auriniapharma.com
AUPH | $5.085 0.69% 0.59% 920K
|
Health Technology
|
| O: 0.78%
H: 1.35%
C: -1.93%
lupkynis treatment lupus authorization
Aurinia Announces European Commission Approval of LUPKYNIS® (voclosporin) for the Treatment of Lupus Nephritis
Published: 2022-09-19 (Crawled : 15:20) - ir.auriniapharma.com
AUPH | $5.085 0.69% 0.59% 920K
|
Health Technology
|
| O: -1.1%
H: 6.44%
C: 5.82%
lupkynis treatment lupus approval
Aurinia Announces Positive CHMP Opinion for LUPKYNIS® (voclosporin) for the Treatment of Adults with Active Lupus Nephritis in Europe
Published: 2022-07-22 (Crawled : 11:47) - ir.auriniapharma.com
AUPH | $5.085 0.69% 0.59% 920K
|
Health Technology
|
| O: 2.76%
H: 1.67%
C: -3.98%
lupkynis treatment europe active chmp lupus positive
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.